Submitted by Administrator on Sun, 06/11/2016 - 17:05
The decision by the United States Supreme Court to deny the petition for review in Ariosa Diagnostics v Sequenom placed the patenting of diagnostic tests to the forefront of medical policy, bringing into sharp focus the potential conflict between facilitating access to the latest diagnostic techniques and encouraging invention and commercialisation.
Against this backdrop, the Centre for Law, Medicine and Life Sciences, together with the Centre for Science and Policy, hosted an Expert Workshop on genomic medicine and intellectual property on 6th September, bringing together academics, law professionals, medical practitioners and policy makers.
More information about the discussions at this Workshop can be found here.